Riskpilot← Back to searchSign inGet full accessPrearm Group AB
ABActiveOrg 5591869408Kråkbärsstigen 6Construction of residential and non-residential buildings · NACE 4100Est. 20183 employees
Revenue 2024
SEK 4,5M
-71% vs 2023
EBITDA margin
24.9%
-38% vs 2023
Equity ratio
25.9%
Financial strength
Net profit 2024
SEK 662K
-39% vs 2023
| Revenue | SEK 4,5M | -71% |
| EBITDA | SEK 1,1M | -38% |
| Net profit | SEK 662K | -39% |
| Total assets | SEK 3,4M | -49% |
| Equity | SEK 876K | -68% |
| Employees | 3 | — |
Legal name
Prearm Group AB
Org number
5591869408
Legal form
Aktiebolag
NACE code
4100 · Construction of residential and non-residential buildings
Founded
18 december 2018
Share capital
SEK 60 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva byggverksamhet och konsultationer inom byggbranschen samt därmed förenlig verksamhet.
Address
Kråkbärsstigen 6
Email
info@prearm.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 174 | 13 970 | 10 061 | 15 657 | 4 489 |
| Staff expenses | — | — | −2 398 | −2 657 | −2 658 |
| EBITDA | 1 151 | 2 387 | 1 093 | 1 807 | 1 118 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 1 151 | 2 387 | 1 093 | 1 807 | 1 118 |
| Net financials | — | — | −1 | 47 | 47 |
| Profit before tax | 861 | 1 783 | 812 | 1 374 | 854 |
| Tax | −187 | −373 | −172 | −297 | −192 |
| Net profit | 674 | 1 410 | 640 | 1 078 | 662 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 812 | 4 738 | 5 134 | 6 675 | 3 386 |
| Equity | 1 138 | 2 547 | 1 687 | 2 765 | 876 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 1 384 | 1 296 | 2 273 | 2 257 | 545 |
| Total debt | 1 384 | 1 296 | 2 273 | 2 257 | 545 |
EBITDA margin
24.9%
This company
15.8%
Market median
+58% vs market
20202024
Equity ratio
25.9%
This company
38.2%
Market median
-32% vs market
20202024
Return on equity
75.5%
This company
18.4%
Market median
+310% vs market
20202024
Net profit margin
14.7%
This company
8.1%
Market median
+81% vs market
20202024
Asset turnover
1.33×
This company
1.12×
Market median
+19% vs market
20202024
Debt / equity
2.86×
This company
0.62×
Market median
-361% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JL Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
CC Chief Auditor | Chief Auditor | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Prearm Group AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Josef Lasse Bergerheim | Chief Auditor | 0 companies |
| Carl Christian Andersson | Chief Auditor | 0 companies |
| Dorde Lazarevic | Board of Directors | 0 companies |
| Elias Ilia Kensborn | Chairman | 0 companies |
| Szymon Borsuk | Board of Directors | 0 companies |